Synergistic Nanocellulose Systems for Enhanced Therapeutic Delivery
Legal Citation
Summary of the Inventive Concept
This inventive concept integrates nanocellulose-derived hydrogel matrices with distinct technologies such as AI, IoT, blockchain, and smart materials to create novel systems for enhanced therapeutic delivery, personalized medicine, and real-time monitoring.
Background and Problem Solved
The original patent disclosed a nanocellulose-derived hydrogel drug delivery system for providing extended release in oral dosing pharmaceuticals. However, the original system had limitations in terms of patient adherence, personalized dosing, and real-time monitoring. The new inventive concept addresses these limitations by integrating the nanocellulose-derived hydrogel matrix with emerging technologies to create a more powerful and comprehensive system.
Detailed Description of the Inventive Concept
The inventive concept comprises four distinct systems: 1) a blockchain-based tracking system for monitoring patient adherence, 2) an AI-driven predictive analytics system for personalized oral dosing of therapeutic agents, 3) a wearable device for transdermal insulin delivery incorporating a nanocellulose-based hydrogel reservoir and IoT-enabled real-time glucose monitoring, and 4) a novel excipient for oral pharmaceuticals comprising a nanocellulose-based hydrogel matrix and a smart material responsive to environmental stimuli. Each system leverages the unique properties of nanocellulose-derived hydrogel matrices to enhance therapeutic delivery and patient outcomes.
Novelty and Inventive Step
The new claims introduce a synergistic combination of nanocellulose-derived hydrogel matrices with emerging technologies, providing a novel and non-obvious solution for enhanced therapeutic delivery and personalized medicine. The integration of these technologies enables real-time monitoring, improved patient adherence, and optimized treatment outcomes, which are not achievable with the original patent's standalone nanocellulose-derived hydrogel drug delivery system.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different types of hydrogel matrices, various AI-driven predictive analytics algorithms, or the integration of additional emerging technologies such as augmented reality or 5G networks. These variations could enable further customization and adaptation of the systems to specific therapeutic applications and patient needs.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine, real-time monitoring, and targeted therapeutic delivery. The market for these systems is expected to grow significantly in the coming years, driven by the increasing demand for more effective and efficient healthcare solutions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K47/38 |
| A | A61 | A61K47/40 |
| A | A61 | A61L27/20 |
| A | A61 | A61L27/52 |
| B | B82 | B82Y5/00 |
| B | B82 | B82Y30/00 |
| B | B82 | B82Y40/00 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical drug delivery systems, nanomaterials, and biomedical engineering, with expertise in hydrogel matrices, drug encapsulation technologies, and advanced material design for therapeutic applications
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in chemical engineering, materials science, or pharmaceutical sciences, possessing knowledge of nanocellulose technologies, drug delivery mechanisms, and emerging biotechnological integration strategies
Obviousness Rationale
A PHOSITA would recognize that integrating emerging technologies like AI, blockchain, and IoT with existing nanocellulose hydrogel drug delivery systems represents a predictable extension of known technological convergence strategies. The fundamental drug delivery mechanism remains consistent with the source patent, while the added technological layers provide enhanced monitoring and personalization capabilities. These variations represent logical combinations of known techniques in drug delivery and digital health technologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,632 |
|---|---|
| Title | Nanocellulose as an embedding matrix and applications thereof |
| Assignee(s) | INNOSENSE LLC |